These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 2166345

  • 1. New directions in non-small cell lung cancer.
    Gralla RJ.
    Semin Oncol; 1990 Aug; 17(4 Suppl 7):14-9. PubMed ID: 2166345
    [Abstract] [Full Text] [Related]

  • 2. The treatment of non-small cell lung cancer: current perspectives and controversies, future directions.
    Bunn PA.
    Semin Oncol; 1994 Jun; 21(3 Suppl 6):49-59. PubMed ID: 8052874
    [Abstract] [Full Text] [Related]

  • 3. Current management of unresectable non-small cell lung cancer.
    Livingston RB.
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):4-11; discussion 11-3. PubMed ID: 7973768
    [Abstract] [Full Text] [Related]

  • 4. Investigations of new drugs in combination with cisplatin in stage III non-small cell lung cancer.
    Vokes EE, Leopold KA, Herndon J, Green MR.
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-42-S8-45. PubMed ID: 9207317
    [Abstract] [Full Text] [Related]

  • 5. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
    Machtay M, Lee JH, Stevenson JP, Shrager JB, Algazy KM, Treat J, Kaiser LR.
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
    [Abstract] [Full Text] [Related]

  • 6. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
    Hainsworth JD, Greco FA.
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Drug therapy in bronchial carcinoma].
    Manegold C, Drings P.
    Schweiz Med Wochenschr; 1995 Jul 22; 125(29):1396-405. PubMed ID: 7545824
    [Abstract] [Full Text] [Related]

  • 9. [Combined modality treatment of chemotherapy and radiotherapy for unresectable non-small cell lung cancer].
    Kubota K.
    Gan To Kagaku Ryoho; 1997 Oct 22; 24 Suppl 3():384-9. PubMed ID: 9369912
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The expanding role of cisplatin in the treatment of non-small-cell lung cancer.
    Bunn PA.
    Semin Oncol; 1989 Aug 22; 16(4 Suppl 6):10-21. PubMed ID: 2548280
    [Abstract] [Full Text] [Related]

  • 12. A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209).
    Nagai K, Tsuchiya R, Mori T, Tada H, Ichinose Y, Koike T, Kato H, Lung Cancer Surgical Study Group of the Japan Clinical Oncology Group.
    J Thorac Cardiovasc Surg; 2003 Feb 22; 125(2):254-60. PubMed ID: 12579093
    [Abstract] [Full Text] [Related]

  • 13. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.
    Srisam-Ang K, Podhipak A, Narksawat K, Supaattagorn P, Tipayamongkholgul M.
    Southeast Asian J Trop Med Public Health; 2005 Jul 22; 36(4):994-1006. PubMed ID: 16295558
    [Abstract] [Full Text] [Related]

  • 14. Future directions in the treatment of non-small cell lung cancer.
    Shepherd FA.
    Semin Oncol; 1994 Jun 22; 21(3 Suppl 4):48-62. PubMed ID: 8209277
    [Abstract] [Full Text] [Related]

  • 15. Chemotherapy for unresectable non-small cell lung cancer.
    Johnson DH.
    Semin Oncol; 1990 Aug 22; 17(4 Suppl 7):20-9. PubMed ID: 2166346
    [Abstract] [Full Text] [Related]

  • 16. Sequential chemoradiation therapy with vinorelbine, ifosfamide, and cisplatin in stage IIIB non-small cell lung cancer: a phase II study.
    Baldini E, Silvano G, Tibaldi C, Campoccia S, Cionini L, Conte P.
    Semin Oncol; 2000 Feb 22; 27(1 Suppl 1):28-32. PubMed ID: 10697041
    [Abstract] [Full Text] [Related]

  • 17. [New therapeutic strategies and current research in inoperable locally advanced non small-cell lung cancers (stage IIIB)].
    Le Cesne A, Arriagada R, Grunenwald D, Baldeyrou P, Girard P, Bretel JJ, Le Chevalier T.
    Bull Cancer; 1997 Apr 22; 84(4):413-9. PubMed ID: 9238166
    [Abstract] [Full Text] [Related]

  • 18. [Second line chemotherapy in patients with refractory and resistant non small cell lung cancer].
    Jacoulet P, Dubiez A, Westeel V, Polio JC, Pernet D, Depierre A.
    Rev Mal Respir; 1997 Jan 22; 14(1):29-35. PubMed ID: 9082503
    [Abstract] [Full Text] [Related]

  • 19. The treatment of inoperable patients with non-small-cell lung cancer.
    Feld R.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Dec 22; 32 Suppl():19-24. PubMed ID: 7602831
    [No Abstract] [Full Text] [Related]

  • 20. The role of multimodality therapy in locoregional non-small cell lung cancer.
    Martini N, Kris MG, Ginsberg RJ.
    Surg Oncol Clin N Am; 1997 Oct 22; 6(4):769-91. PubMed ID: 9309093
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.